Heyu Biological Technology Corporation
HYBT · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $148,022 | $128,451 | $1,445 | $103 |
| - Cash | $241 | $896 | $11 | $4 |
| + Debt | $6,798 | $0 | $0 | $58 |
| Enterprise Value | $154,580 | $127,555 | $1,434 | $157 |
| Revenue | $2,867 | $2,676 | $79 | $96 |
| % Growth | 7.1% | 3,289.4% | -18.2% | – |
| Gross Profit | $182 | $69 | $52 | $66 |
| % Margin | 6.3% | 2.6% | 65.3% | 68.6% |
| EBITDA | -$377 | -$470 | -$266 | -$163 |
| % Margin | -13.1% | -17.6% | -336.6% | -168.8% |
| Net Income | -$472 | -$379 | -$265 | -$163 |
| % Margin | -16.5% | -14.2% | -336.1% | -169% |
| EPS Diluted | -0.001 | -0.001 | -0 | -0 |
| % Growth | -12.5% | -166.7% | -50% | – |
| Operating Cash Flow | -$7,338 | $751 | -$292 | -$141 |
| Capital Expenditures | -$4,022 | -$40,596 | $0 | $0 |
| Free Cash Flow | -$11,360 | -$39,846 | -$292 | -$141 |